ConductScience.org, home

Paper154122

Natural inhibitors of fibrinolysis.

Aoki N. Prog Cardiovasc Dis, 1979. Cited by 62 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Natural inhibitors of fibrinolysis. Papers, record 154122. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/154122

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural inhibitors of fibrinolysis.
PubMed
Journal
Prog Cardiovasc Dis
PubMed
Year
1979
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
62
iCite
Relative citation ratio, by iCite
2.46
iCite
Revised in PubMed
2019-09-18
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aoki NN

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifibrinolytic AgentsMajor topic
Blood Coagulation DisordersMajor topic
Blood Coagulation FactorsMajor topic
FibrinolysisMajor topic
Animals
Disseminated Intravascular Coagulation
Embolism
Female
Fibrinolysin
Haplorhini
Humans
Kidney Diseases
Liver
Plasminogen
Pregnancy
Protease Inhibitors
Rabbits
Thrombophlebitis

Source PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMIDTitleJournalYearIn PapersSource
7,199,538Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.J Clin Invest1982https://conductscience.org/library/papers/7199538PubMed
7,018,088Thrombosis: its role and prevention in cardiovascular events-Part II.West J Med1981https://conductscience.org/library/papers/7018088PubMed
6,448,870Natural inhibitors of fibrinolysis.J Clin Pathol Suppl (R Coll Pathol)1980https://conductscience.org/library/papers/6448870PubMed
6,444,305Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.J Clin Invest1980https://conductscience.org/library/papers/6444305PubMed
6,291,058Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6291058PubMed
3,166,140Organization of the human alpha 2-plasmin inhibitor gene.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3166140PubMed
2,496,145Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence.J Clin Invest1989https://conductscience.org/library/papers/2496145PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/154122

GET https://conductscience.org/api/papers/v1/154122/authors